Roche Klonopin anti-generic campaign includes letters to physicians, journal ads for perforated tabs.
Executive Summary
GENERIC CLONAZEPAM DOES NOT MEET KLONOPIN DISSOLUTION STANDARDS, ROCHE CLAIMS in a recent mailing to physicians and pharmacists. "Our tests of the Teva Pharmaceuticals brand of clonazepam tablets indicate that some batches of the product do not meet the dissolution standards that the FDA requires Klonopin tablets to meet," the cover letter asserts. Roche adds that "we have no evidence that the Teva product is not bioequivalent to Klonopin, but the disparity in dissolution standards is, in our view, unwarranted."